CSIMarket
 


Kinnate Biopharma Inc   (KNTE)
Other Ticker:  
 

Cumulative Kinnate Biopharma Inc 's Leverage Ratio for Trailing Twelve Months Period

KNTE's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

KNTE Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -30.57 % -27.8 % -24.7 % -30.05 % -27.18 %
Y / Y Total Liabilities Growth -66 % -63.09 % -60 % -32.81 % -33.01 %
Leverage Ratio for Trailing Twelve Months Period 0.14 0.17 0.19 0.2 0.21
Total Ranking # 260 # 371 # 458 # 592 # 516
Seq. Equity Growth -12.75 % -11.29 % -0.32 % -10.02 % -9.27 %
Seq. Total Liabilities Growth -1.22 % -12.33 % -61.85 % 2.91 % 7.23 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to debt repayement of -1.22% Kinnate Biopharma Inc decreased Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 0.14, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 72 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Kinnate Biopharma Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are KNTE's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 73
Sector # 104
S&P 500 # 178


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.2 0.16 0.14
(Dec 31 2022)   (Dec 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Mira Pharmaceuticals Inc   0.38 
Azitra Inc   0.38 
Biomarin Pharmaceutical Inc  0.38 
Merus N v   0.38 
Vistagen Therapeutics Inc   0.38 
Arbutus Biopharma Corp  0.37 
Zymeworks Inc   0.36 
Centessa Pharmaceuticals Plc  0.36 
Tiziana Life Sciences Ltd  0.35 
Acurx Pharmaceuticals inc   0.35 
Nurix Therapeutics Inc   0.35 
Arrowhead Pharmaceuticals Inc   0.34 
Gain Therapeutics inc  0.34 
Evotec Se  0.34 
Benitec Biopharma Inc   0.33 
Regulus Therapeutics Inc   0.33 
Genelux Corporation  0.33 
Bolt Biotherapeutics Inc   0.33 
Universe Pharmaceuticals Inc  0.32 
Longeveron Inc   0.32 
Neximmune Inc   0.32 
Praxis Precision Medicines Inc   0.31 
Vincerx Pharma Inc   0.31 
Hcw Biologics Inc   0.31 
Avricore Health Inc   0.31 
Nkarta Inc   0.31 
Vertex Pharmaceuticals Inc  0.31 
23andme Holding Co  0.30 
Bionomics Limited  0.30 
Stoke Therapeutics Inc   0.30 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com